Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma
Authors:
- 1 December 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 37 (12) , 1267-1272
Abstract
Purpose The aim of this retrospective study was to determine whether glucose metabolism assessed by fluorine-18 fluorodeoxyglucose (18F-FDG) PET/computed tomography (CT) provides prognostic information independent of established prognostic factors in patients with gastric lymphoma. Patients and methods We reviewed the medical records of 86 patients retrospectively (men, 42; women, 44; mean age 58±13 years) with pathologically proven gastric lymphoma (34 mucosa-associated lymphoid tissue and 52 aggressive non-Hodgkin’s lymphoma). They underwent 18F-FDG PET/CT as part of a pretreatment work-up from February 2004 to July 2012. For the analysis, patients were classified by age, sex, Musshoff stage, serum lactate dehydrogenase, International Prognostic Index score, extragastric spread, and visual intensity [visual assessment and maximum standardized uptake value (SUVmax), respectively]. The relationship between 18F-FDG uptake and survival was analyzed using the Kaplan–Meier method with a log-rank test and Cox’s proportional-hazard regression method. Results The median survival of all 86 study participants was 1117 days and the median SUV measured by PET/CT was 6.1 (range, 1.9–32.7). Patients with an SUVmax less than or equal to 5.2 survived significantly longer than patients with an SUVmax more than 5.2 (median, 1163 vs. 1004 days; P=0.003). Survival was also found to be significantly related to age (P=0.0005), histological type (P=0.004), extragastric spread (P=0.0004), International Prognostic Index score (PP=0.02), stage (PP=0.041). A multivariate analysis showed that patients with a higher SUVmax [P=0.021; 95% confidence interval (CI), 1.52–8.14; hazard ratio (HR)=6.29], older age (P=0.001; 95% CI, 4.64–219.96; HR=18.8), more aggressive histologic type (P=0.006; 95% CI, 2.20–70.63; HR=12.76), and higher stage (P=0.0006; 95% CI, 5.81–206.43; HR=17.48) showed worse survival. Conclusion A higher SUVmax on pretreatment 18F-FDG PET/CT can predict poorer survival in patients with gastric lymphoma.Keywords
This publication has 12 references indexed in Scilit:
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphomaInternational Journal of Hematology, 2011
- Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS groupEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcomeNuclear Medicine Communications, 2009
- FDG avidity and PET/CT patterns in primary gastric lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Intensity of18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2005
- Lymphomatous involvement of gastrointestinal tract: Evaluation by positron emission tomography with18F-fluorodeoxyglucoseWorld Journal of Gastroenterology, 2005
- Non-Hodgkin Lymphoma and Hodgkin Disease: Coregistered FDG PET and CT at Staging and Restaging—Do We Need Contrast-enhanced CT?Radiology, 2004
- Primary gastric lymphomaWorld Journal of Gastroenterology, 2004
- Treatment of extranodal lymphomasBest Practice & Research Clinical Haematology, 2002
- Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literatureCancer, 1989